FDA statement on vaccines and related biological products advisory committee meeting

News

The following is attributed to FDA Commissioner Stephen M. Hahn, M.D., and Peter Marks, M.D., Ph.D., director of the FDA’s Center for Biologics Evaluation and Research.

COVID-19 vaccination record card with vials and syringe. Pfizer, Moderna, Johnson & Johnson. Getty Images.

WASHINGTON (PRESS RELEASE) — Following Thursday’s, December 10, positive advisory committee meeting outcome regarding the Pfizer-BioNTech COVID-19 vaccine, the U.S. Food and Drug Administration has informed the sponsor that it will rapidly work toward finalization and issuance of an emergency use authorization.

The agency has also notified the U.S. Centers for Disease Control and Prevention and Operation Warp Speed, so they can execute their plans for timely vaccine distribution.

The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices.

The agency also is responsible for the safety and security of our nation’s food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products.

Copyright 2021 Nexstar Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Latest Video

FOX24 Video

TOP STORIES

More News

DON'T MISS

More Don't Miss

Trending Stories

Follow KNWA & FOX24 on Facebook

get the app

News App

Weather App

Follow @KNWAFOX24 on Twitter

Mega Millions & Powerball Numbers